Evidence map›Paper›PMID 35287764›Full record

ArticleImplementation science communications2022

Preparing for the spread of patient-reported outcome (PRO) data collection from primary care to community pharmacy: a mixed-methods study.

Omolola A Adeoye-Olatunde, Geoffrey M Curran, Heather A Jaynes, Lisa A Hillman, Nisaratana Sangasubana, Betty A Chewning, David H Kreling, Jon C Schommer, Matthew M Murawski, Susan M Perkins and 1 more

Abstract read
In one paragraph

Article in Implementation science communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Real-World Evaluation of an EHR-Enabled Chronic Obstructive Pulmonary Disease Assessment Test.International journal of chronic obstructive pulmonary disease · 2025
    Observational
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Omolola A Adeoye-OlatundePurdue University College of Pharmacy, 640 Eskenazi Avenue, Fifth Third Bank Building, Indianapolis, IN, 46202, USA. adeoyeo@purdue.edu.ORCID http://orcid.org/0000-0002-2907-3524
Geoffrey M CurranUniversity of Arkansas for Medical Sciences College of Pharmacy, 4301 W. Markham St., #522-4, Little Rock, AR, 72205-7199, USA.
Heather A JaynesPurdue University College of Pharmacy, 640 Eskenazi Avenue, Fifth Third Bank Building, Indianapolis, IN, 46202, USA.
Lisa A HillmanUniversity of Minnesota, College of Pharmacy, 308 Harvard Street, SE, Minneapolis, MN, 55455, USA.
Nisaratana SangasubanaUniversity of Wisconsin-Madison School of Pharmacy, 777 Highland Ave., Madison, WI, 53704, USA.
Betty A ChewningUniversity of Wisconsin-Madison School of Pharmacy, 777 Highland Ave., Madison, WI, 53704, USA.
David H KrelingUniversity of Wisconsin-Madison School of Pharmacy, 777 Highland Ave., Madison, WI, 53704, USA.
Jon C SchommerUniversity of Minnesota, College of Pharmacy, 308 Harvard Street, SE, Minneapolis, MN, 55455, USA.
Matthew M MurawskiPurdue University College of Pharmacy, 575 Stadium Mall Drive, Heine Pharmacy Building, West Lafayette, IN, 47907, USA.
Susan M PerkinsIndiana University School of Medicine, 410 W 10th Street, Indianapolis, IN, 46202, USA.
Margie E SnyderPurdue University College of Pharmacy, 640 Eskenazi Avenue, Fifth Third Bank Building, Indianapolis, IN, 46202, USA.

Funding

Expanding Translational Research in ArkansasUL1TR003107 · NCATS · UNIV OF ARKANSAS FOR MED SCIS · PI JAMES, LAURA P · 2019 to 2023
$21.6M
Indiana Clinical and Translational Sciences InstituteTL1TR001107 · NCATS · INDIANA UNIVERSITY INDIANAPOLIS · PI DENNE, SCOTT C., SHEKHAR, ANANTHA · 2013 to 2017
$2.0M
AHRQ HHS R18 HS025943AHRQ HHS R18HS025943NCATS NIH HHS TL1 TR001107NCATS NIH HHS TL1TR001107NCATS NIH HHS UL1 TR003107NCATS NIH HHS UL1TR003107
6 · The paper itself

Abstract

backgroundMedication non-adherence is a significant public health problem. Patient-reported outcomes (PROs) offer a rich data source to facilitate resolution of medication non-adherence. PatientToc™ is an electronic PRO data collection software originally implemented at primary care practices in California, United States (US). Currently, the use of standardized PRO data collection systems in US community pharmacies is limited. Thus, we are conducting a two-phase evaluation of the spread and scale of PatientToc™ to US Midwestern community pharmacies. This report focuses on the first phase of the evaluation. The objective of this phase was to prepare for implementation of PatientToc™ in community pharmacies by conducting a pre-implementation developmental formative evaluation to (1) identify potential barriers, facilitators, and actionable recommendations to PatientToc™ implementation and (2) create a draft implementation toolkit.

methodsData collection consisted of demographics, observations, audio-recorded contextual inquiries, and semi-structured interviews with staff (e.g., primary care providers, pharmacists, pharmacy technicians) and patients during 1-day site visits to a purposive sample of (1) primary care practices currently using PatientToc™ and (2) community pharmacies in Indiana, Wisconsin, and Minnesota interested in the future use of PatientToc™. Post-visit site observation debriefs were also audio-recorded. Verbatim transcripts of all recordings were coded using deductive/inductive approaches and intra-/inter-site summaries were produced identifying potential barriers, facilitators, and actionable recommendations mapped to the Consolidated Framework for Implementation Research constructs. A stakeholder advisory panel engaged in an Evidence-Based Quality Improvement (EBQI) implementation process. This included "member checking" and prioritizing findings, and feedback on the adapted PatientToc™ application, implementation strategies, and accompanying toolkit for community pharmacy implementation.

resultsTwo primary care practices, nine pharmacies, and 89 individuals participated. Eight major themes (four barriers and four facilitators) and 14 recommendations were identified. Throughout the four EBQI sessions, the panel (1) confirmed findings; (2) designated high priority recommendations: (a) explain PatientToc™ and its benefits clearly and simply to patients, (b) ensure patients can complete questionnaires within 10 min, and (c) provide hands-on training/resources for pharmacy teams; and (3) provided feedback on the adapted PatientToc™ application and finalized toolkit items for initial community pharmacy implementation.

conclusionsAdoption of electronically captured PROs in community pharmacies is warranted. The implementation strategies systematically developed in this study can serve as a model for implementation of technology-driven health information patient care services, in the understudied context of community pharmacies.

Indexed as

Community pharmacyHealth information technologyPatient-reported outcomes

Identifiers

PMID35287764
PMCPMC8919161

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.